Author: Li, Mei-Ling; Shih, Shin-Ru; Tolbert, Blanton S.; Brewer, Gary
Title: Enterovirus A71 Vaccines Cord-id: b3ldvnza Document date: 2021_2_27
ID: b3ldvnza
Snippet: Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under de
Document: Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.
Search related documents:
Co phrase search for related documents- adaptive immunity and long last immunity: 1
- adaptive immunity and long term persistence: 1
Co phrase search for related documents, hyperlinks ordered by date